Why It Matters
A federal circuit split on whether the Dormant Commerce Clause constrains state marijuana licensing has left the cannabis industry in legal limbo, according to a recent Congressional Research Service report. The Second Circuit found that New York's marijuana licensing program likely violated the Dormant Commerce Clause in a preliminary injunction decision; the First Circuit held in a 2-1 decision that Maine's residency requirement for dispensary officers and directors violated the Dormant Commerce Clause, and the Ninth Circuit held unanimously that the Dormant Commerce Clause is inapplicable to marijuana markets that Congress has made illegal. This disagreement directly affects out-of-state investors and cannabis business operators navigating a fractured regulatory landscape.
A majority of states have legalized some form of marijuana activity, yet all state recreational programs remain federal crimes under the Controlled Substances Act. The April 2026 Department of Justice rescheduling order created a narrow federal accommodation for medical marijuana products that are either FDA-approved or covered by a state-issued medical marijuana license, but no FDA-approved marijuana-derived products currently qualify. The circuit split persists unresolved, and the Supreme Court has not yet granted certiorari on the question.
The Big Picture
The constitutional conflict centers on whether the Dormant Commerce Clause, an implied restraint on state economic regulation derived from Article I, Section 8, Clause 3, applies to markets Congress has explicitly criminalized. The Second Circuit in Variscite NY 4 v. N.Y. State Cannabis Control Board held in a 2-1 decision that New York's marijuana licensing program likely violated the doctrine in a preliminary injunction ruling, reasoning that Congress disapproving of a market is not the same as Congress approving protectionist measures within it. The court warned that allowing states to create advantages for their residents in marijuana licensing would distort a national market if Congress later chose to legalize marijuana.
The First Circuit in Northeast Patients Group v. United Cannabis Patients and Caregivers of Maine reached a similar conclusion in a 2-1 decision, striking down Maine's residency requirement for dispensary officers and directors. The First Circuit rejected Maine's argument that the Dormant Commerce Clause does not apply to illegal markets, and pointed to Congress's repeated enactment of appropriations riders barring the Department of Justice from interfering with state medical marijuana programs as evidence that Congress was aware of the interstate marijuana market.
The Ninth Circuit took the opposite view. In Peridot Tree v. Washington State Liquor and Cannabis Control Board, the court held unanimously that the Dormant Commerce Clause is inapplicable to marijuana markets that Congress has made illegal. The Ninth Circuit reasoned that the doctrine's purpose is to preserve a national market for goods and services, but that protection does not extend to a market Congress has prohibited. It emphasized the Supreme Court's instruction that the Dormant Commerce Clause should be invoked with extreme caution and extreme delicacy.
Many state marijuana regimes favor in-state residents through licensing requirements such as residency periods or priority for individuals with prior marijuana convictions under that state's laws.
The Bottom Line
Rescheduling marijuana without descheduling leaves the constitutional question unresolved and the circuit split intact. Congressional authorization of interstate cannabis commerce would supersede the Dormant Commerce Clause question by directly authorizing or prohibiting such commerce. The circuit split creates a two-tier regulatory environment and investor uncertainty.
Access the Legis1 platform for comprehensive political news, data, and insights
Spot something wrong? Report an issue with this article